<DOC>
	<DOCNO>NCT02144064</DOCNO>
	<brief_summary>Objective To determine maternal fetal outcome woman APS manage aspirin unfractionated heparin ( UFH ) plus aspirin pregnancy . Design : prospective clinical control study . Setting : high-risk pregnancy unit- Benha university hospital . Methods : Pregnant woman recurrent miscarriage attend high-risk pregnancy unit . 140 selected patient previous recurrent miscarriage divide 2 group : group A ( n = 70 ) receive low-dose aspirin ( 81 mg daily orally ) plus heparin ( 5000 IU ) every 12 h ﬁrst positive pregnancy test group B ( n = 70 ) receive thing . Main outcome measure : Maternal outcome include thromboembolic haemorrhagic complication pregnancy-induced hypertension .Prematurity , intrauterine growth restriction neonatal death consider maternal fetal complication</brief_summary>
	<brief_title>Pregnancy Outcomes Women With Recurrent Miscarriage Treated With Low Dose Aspirin Unfractionated Heparin</brief_title>
	<detailed_description>This prospective comparative , control clinical study conduct Department Obstetrics Gynecology , Benha University Hospital , private center , June 2012 . After approval study protocol Local Ethical Committee obtain write fully inform patient ' consent . All patient interview medical , personal , family , obstetrical thrombosis history . All patient include study complain three unexplained consecutive spontaneous abortion . All patient ( n=140 ) good general health without previous history Diabetes Mellitus thyroid dysfunction cardiac disease . Patients Thrombocytopenia ( &lt; 100000/ml ) , bleed tendency , ectopic pregnancy , past history vascular thrombosis , uterine anomaly multiple gestation exclude study . complete blood picture , urine routine examination , blood sugar , blood grouping , Bleeding Time , Clotting Time , Prothrombin Time , Activated Partial Thromboplastin Time , Hepatitis B Surface Ag , Hepatitis C Virus screen offer patient finding note soon conceive . All patient give routine Folic Acid , Iron Calcium supplementation orally daily antenatal period ( whether conceive spontaneously treatment 140 select patient previous recurrent miscarriage divide 2 group : Group A ( n = 70 ) put Inj . UFH ( Cal-heparin ) 5000 U subcutaneous twice daily plus Aspirin 81 mg/day ( Juspirin ) ﬁrst positive pregnancy test , Inj . UFH give either anterior abdominal wall anterior aspect thigh subcutaneously . While group B ( n = 70 ) receive thing</detailed_description>
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<mesh_term>Abortion , Habitual</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<criteria>patient recurrent pregnancy loss ( RPL ) previous history Diabetes Mellitus thyroid dysfunction cardiac disease Thrombocytopenia ( &lt; 100000/ml ) bleeding tendency ectopic pregnancy past history vascular thrombosis uterine anomaly multiple gestation</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>46 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Aspirin , heparin , pregnancy , recurrent miscarriage</keyword>
</DOC>